19-40403757-G-C

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_181882.3(PRX):ā€‹c.133C>Gā€‹(p.Arg45Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00119 in 1,587,824 control chromosomes in the GnomAD database, including 28 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0060 ( 15 hom., cov: 32)
Exomes š‘“: 0.00068 ( 13 hom. )

Consequence

PRX
NM_181882.3 missense

Scores

1
6
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts U:1B:8

Conservation

PhyloP100: 1.99
Variant links:
Genes affected
PRX (HGNC:13797): (periaxin) This gene encodes a protein involved in peripheral nerve myelin upkeep. The encoded protein contains 2 PDZ domains which were named after PSD95 (post synaptic density protein), DlgA (Drosophila disc large tumor suppressor), and ZO1 (a mammalian tight junction protein). Two alternatively spliced transcript variants have been described for this gene which encode different protein isoforms and which are targeted differently in the Schwann cell. Mutations in this gene cause Charcot-Marie-Tooth neuoropathy, type 4F and Dejerine-Sottas neuropathy. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0031335056).
BP6
Variant 19-40403757-G-C is Benign according to our data. Variant chr19-40403757-G-C is described in ClinVar as [Benign]. Clinvar id is 284652.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr19-40403757-G-C is described in Lovd as [Benign]. Variant chr19-40403757-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.006 (912/152044) while in subpopulation AFR AF= 0.0209 (867/41444). AF 95% confidence interval is 0.0198. There are 15 homozygotes in gnomad4. There are 455 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 15 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PRXNM_181882.3 linkc.133C>G p.Arg45Gly missense_variant 5/7 ENST00000324001.8 NP_870998.2 Q9BXM0-1
PRXNM_001411127.1 linkc.418C>G p.Arg140Gly missense_variant 5/7 NP_001398056.1
PRXNM_020956.2 linkc.133C>G p.Arg45Gly missense_variant 5/6 NP_066007.1 Q9BXM0-2
PRXXM_017027047.2 linkc.-100C>G upstream_gene_variant XP_016882536.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PRXENST00000324001.8 linkc.133C>G p.Arg45Gly missense_variant 5/71 NM_181882.3 ENSP00000326018.6 Q9BXM0-1

Frequencies

GnomAD3 genomes
AF:
0.00598
AC:
908
AN:
151926
Hom.:
15
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0209
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00197
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.00433
GnomAD3 exomes
AF:
0.00153
AC:
318
AN:
207882
Hom.:
6
AF XY:
0.00115
AC XY:
130
AN XY:
113436
show subpopulations
Gnomad AFR exome
AF:
0.0211
Gnomad AMR exome
AF:
0.00153
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000376
Gnomad FIN exome
AF:
0.000340
Gnomad NFE exome
AF:
0.0000552
Gnomad OTH exome
AF:
0.00153
GnomAD4 exome
AF:
0.000681
AC:
978
AN:
1435780
Hom.:
13
Cov.:
32
AF XY:
0.000583
AC XY:
415
AN XY:
712440
show subpopulations
Gnomad4 AFR exome
AF:
0.0229
Gnomad4 AMR exome
AF:
0.00155
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000121
Gnomad4 FIN exome
AF:
0.000262
Gnomad4 NFE exome
AF:
0.0000336
Gnomad4 OTH exome
AF:
0.00172
GnomAD4 genome
AF:
0.00600
AC:
912
AN:
152044
Hom.:
15
Cov.:
32
AF XY:
0.00612
AC XY:
455
AN XY:
74328
show subpopulations
Gnomad4 AFR
AF:
0.0209
Gnomad4 AMR
AF:
0.00196
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000208
Gnomad4 FIN
AF:
0.0000945
Gnomad4 NFE
AF:
0.0000588
Gnomad4 OTH
AF:
0.00428
Alfa
AF:
0.000426
Hom.:
0
Bravo
AF:
0.00682
ESP6500AA
AF:
0.0165
AC:
72
ESP6500EA
AF:
0.000117
AC:
1
ExAC
AF:
0.00161
AC:
194
Asia WGS
AF:
0.00202
AC:
7
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Uncertain:1Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Nov 19, 2015- -
Benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsFeb 25, 2021- -
not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxMay 10, 2018This variant is associated with the following publications: (PMID: 25164601) -
Likely benign, no assertion criteria providedclinical testingClinical Genetics, Academic Medical Center-- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria providedliterature onlyInherited Neuropathy Consortium-- -
Charcot-Marie-Tooth disease type 4F Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Charcot-Marie-Tooth disease type 4 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 08, 2025- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.34
BayesDel_addAF
Benign
-0.41
T
BayesDel_noAF
Benign
-0.35
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.22
.;T
Eigen
Benign
0.061
Eigen_PC
Benign
0.081
FATHMM_MKL
Benign
0.61
D
LIST_S2
Uncertain
0.87
D;D
MetaRNN
Benign
0.0031
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.66
N;N
PrimateAI
Uncertain
0.63
T
PROVEAN
Pathogenic
-4.4
D;N
REVEL
Benign
0.12
Sift
Uncertain
0.0030
D;D
Sift4G
Uncertain
0.0080
D;D
Polyphen
0.49
P;D
Vest4
0.43
MVP
0.54
MPC
0.53
ClinPred
0.029
T
GERP RS
2.8
Varity_R
0.40
gMVP
0.79

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs115090201; hg19: chr19-40909664; API